|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karakiewicz PI, Benayoun S, Zippe C,
Lüdecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C, Friedrich
MG, Eissa S, et al: Institutional variability in the accuracy of
urinary cytology for predicting recurrence of transitional cell
carcinoma of the bladder. BJU Int. 97:997–1001. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jacobs BL, Lee CT and Montie JE: Bladder
cancer in 2010: How far have we come? CA Cancer J Clin. 60:244–272.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ploeg M, Aben KK and Kiemeney LA: The
present and future burden of urinary bladder cancer in the world.
World J Urol. 27:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sanchez-Carbayo M, Socci ND, Lozano J,
Saint F and Cordon-Cardo C: Defining molecular profiles of poor
outcome in patients with invasive bladder cancer using
oligonucleotide microarrays. J Clin Oncol. 24:778–789. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clark PE, Agarwal N, Biagioli MC,
Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel
TM, Lele SM, et al: National Comprehensive Cancer Network (NCCN):
Bladder cancer. J Natl Compr Canc Netw. 11:446–475. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bolenz C and Lotan Y: Molecular biomarkers
for urothelial carcinoma of the bladder: Challenges in clinical
use. Nat Clin Pract Urol. 5:676–685. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo G, Sun X, Chen C, Wu S, Huang P, Li Z,
Dean M, Huang Y, Jia W, Zhou Q, et al: Whole-genome and whole-exome
sequencing of bladder cancer identifies frequent alterations in
genes involved in sister chromatid cohesion and segregation. Nat
Genet. 45:1459–1463. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Darwiche N, Freeman LA and Strunnikov A:
Characterization of the components of the putative mammalian sister
chromatid cohesion complex. Gene. 233:39–47. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Taylor CF, Platt FM, Hurst CD, Thygesen HH
and Knowles MA: Frequent inactivating mutations of STAG2 in bladder
cancer are associated with low tumour grade and stage and inversely
related to chromosomal copy number changes. Hum Mol Genet.
23:1964–1974. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Solomon DA, Kim T, Diaz-Martinez LA, Fair
J, Elkahloun AG, Harris BT, Toretsky JA, Rosenberg SA, Shukla N,
Ladanyi M, et al: Mutational inactivation of STAG2 causes
aneuploidy in human cancer. Science. 333:1039–1043. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Djos A, Fransson S, Kogner P and
Martinsson T: Aneuploidy in neuroblastoma tumors is not associated
with inactivating point mutations in the STAG2 gene. BMC Med Genet.
14:1022013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim MS, Kim SS, Je EM, Yoo NJ and Lee SH:
Mutational and expressional analyses of STAG2 gene in solid
cancers. Neoplasma. 59:524–529. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chung NG, Kim MS, Yoo NJ and Lee SH:
Somatic mutation of STAG2, an aneuploidy-related gene, is rare in
acute leukemias. Leuk Lymphoma. 53:1234–1235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kon A, Shih LY, Minamino M, Sanada M,
Shiraishi Y, Nagata Y, Yoshida K, Okuno Y, Bando M, Nakato R, et
al: Recurrent mutations in multiple components of the cohesin
complex in myeloid neoplasms. Nat Genet. 45:1232–1237. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Losada A, Yokochi T, Kobayashi R and
Hirano T: Identification and characterization of SA/Scc3p subunits
in the Xenopus and human cohesin complexes. J Cell Biol.
150:405–416. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jessberger R: Cohesin's dual role in the
DNA damage response: Repair and checkpoint activation. EMBO J.
28:2491–2493. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Balbás-Martínez C, Sagrera A,
Carrillo-de-Santa-Pau E, Earl J, Márquez M, Vazquez M, Lapi E,
Castro-Giner F, Beltran S, Bayés M, et al: Recurrent inactivation
of STAG2 in bladder cancer is not associated with aneuploidy. Nat
Genet. 45:1464–1469. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cha K, Hadjiiski L, Chan HP, Caoili EM,
Cohan RH and Zhou C: CT urography: Segmentation of urinary bladder
using CLASS with local contour refinement. Phys Med Biol.
59:2767–2785. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiao T, Wallace J and Felsenfeld G:
Specific sites in the C terminus of CTCF interact with the SA2
subunit of the cohesin complex and are required for
cohesin-dependent insulation activity. Mol Cell Biol. 31:2174–2183.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Solomon DA, Kim JS, Bondaruk J, Shariat
SF, Wang ZF, Elkahloun AG, Ozawa T, Gerard J, Zhuang D, Zhang S, et
al: Frequent truncating mutations of STAG2 in bladder cancer. Nat
Genet. 45:1428–1430. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cormio L, Sanguedolce F, Massenio P, Di
Fino G, Selvaggio O, Bufo P and Carrieri G: Osseous metaplasia
within a urothelial bladder cancer nodal metastasis: A case report.
Anal Quant Cytopathol Histpathol. 36:117–119. 2014.PubMed/NCBI
|
|
24
|
Zhao H, Yuan X, Jiang J, Wang P, Sun X,
Wang D and Zheng Q: Antimetastatic effects of licochalcone B on
human bladder carcinoma T24 by inhibition of matrix
metalloproteinases-9 and NF-кB activity. Basic Clin Pharmacol
Toxicol. 115:527–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J and Yuan J: Caspases in apoptosis and
beyond. Oncogene. 27:6194–6206. 2008. View Article : Google Scholar : PubMed/NCBI
|
